Adult Child & Adolescent Psychiatric Services
Important Notice: Our clinic will be closed on Monday, September 7, in observance of Labor Day.
We will reopen on Tuesday, September 8, and resume our regular business hours.
SPRAVATO Treatment with Dr. Khan
Your path to rapid relief from treatment-resistant depression.
Why SPRAVATO?
Quick Relief
Experience rapid relief from depressive symptoms.
Personalized Care
Tailored treatments for your unique needs.
Scientific Innovation
Backed by cutting-edge research for lasting results.
Dr. Khan your trusted psychiatrist administers Spravato in a safe and controlled environment
SPRAVATO® for TRD (Treatment-Resistant Depression)
- FDA-Approved for TRD: SPRAVATO® is the only nasal spray approved by the FDA for treatment-resistant depression (TRD).
- NMDA Receptor Antagonist: SPRAVATO® acts on the brain's glutamate pathway via NMDA receptor antagonism, though the exact mechanism is not fully understood.
- Nasal Spray Device: SPRAVATO® is administered through a nasal spray.
